Alzamend Neuro Stock (NASDAQ: ALZN) stock price, news, charts, stock research, profile.
Open | $1.71 |
Close | $1.69 |
Volume / Avg. | 144.66K / 1.60M |
Day Range | $1.66 - $1.73 |
52 Wk Range | 1.60 - 38.97 |
Market Cap | $6.54M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 36 |
Short Interest | 1.84% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Alzamend Neuro (NASDAQ:ALZN) through any online brokerage.
Other companies in Alzamend Neuro’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Virios Therapeutics (NASDAQ:VIRI), Coeptis Therapeutics (NASDAQ:COEP), NuCana (NASDAQ:NCNA) and ABVC BioPharma (NASDAQ:ABVC).
Alzamend Neuro has a consensus price target of $4.75.
The stock price for Alzamend Neuro (NASDAQ: ALZN) is $1.68 last updated September 20, 2024 at 7:46 PM EDT.
There are no upcoming dividends for Alzamend Neuro.
Alzamend Neuro’s Q2 earnings are confirmed for Friday, December 13, 2024.
There is no upcoming split for Alzamend Neuro.
Alzamend Neuro is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.